Test Price
2,800 AED✅ Home Collection Available
KCNE1 Gene (Jervell and Lange‑Nielsen Syndrome Type 2) Next‑Generation Sequencing DNA Test in UAE | 2,800 AED | DHA Licensed
Executive Summary & Core Metrics
UAE‑Trusted Executive Summary
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO‑accredited NGS processing.
- Premium Logistics: VIP Mobile Phlebotomy & temperature-controlled cold-chain home collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary post-test tele-guidance with a Consultant Medical Geneticist.
- Insurance: Direct billing verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The KCNE1 gene test analyses the entire coding region of KCNE1 using Next‑Generation Sequencing (NGS) to identify pathogenic variants linked to Jervell and Lange‑Nielsen syndrome type 2 – a rare autosomal recessive condition that combines congenital sensorineural deafness and a dangerously prolonged QT interval, raising the risk of life‑threatening arrhythmias even in young patients.
| Feature | Our KCNE1 NGS Test | Standard Long‑QT Panel |
|---|---|---|
| Diagnostic Sensitivity | 99.9% for KCNE1 variants | ~95% (broader panel coverage) |
| Methodology | NGS with full gene analysis | Targeted panel or WES |
| Turn‑around Time | 3–4 Weeks | 5–8 Weeks |
| Price (AED) | 2,800 | 4,500 – 6,000 |
| Clinical Support | Complimentary tele-guidance session | Often billable extra |
Physician Insight & Safety Protocols
“Genetic testing for Jervell and Lange‑Nielsen syndrome requires careful correlation with audiometric and electrocardiographic findings. A negative result does not fully exclude a genetic cardiac disorder, and a positive result must be interpreted within the full clinical context. Our commitment is to ensure every patient receives expert pre‑ and post‑test counselling from a qualified genetics professional.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics | DHA ID: 9294403
Medication Advisory
Do not discontinue or change any prescribed medication (especially beta‑blockers or anti‑arrhythmics) without consulting your doctor.
Patient Safety – Exclusion Criteria & Red Flags
- Exclusion Criteria: Active acute coronary syndrome, uncontrolled arrhythmia with hemodynamic instability, current hospitalisation for cardiac event, inability to provide informed consent, or known bleeding disorder that precludes safe phlebotomy.
- Emergency Red Flags (seek immediate medical attention): Sudden syncope (fainting) during exercise or emotional stress, seizure‑like activity, familial sudden unexplained death under 40 years, or new‑onset severe palpitations with chest pain.
- Home collection is not suitable if you are experiencing any of the above red flags – please visit your nearest emergency department.
Patient FAQ & Clinical Guidance
1. What is the purpose of the KCNE1 NGS test and when is it recommended?
This test detects pathogenic DNA variants in the KCNE1 gene to confirm or rule out Jervell and Lange‑Nielsen syndrome type 2, a condition that causes severe cardiac arrhythmias and congenital deafness. It is recommended for individuals with a clinical suspicion of long QT syndrome, especially those presenting with sensorineural hearing loss, family history of sudden cardiac death, or unexplained syncope.
2. How is the sample collected and what pre‑preparations are needed?
A trained phlebotomist collects a small blood sample (whole blood, extracted DNA, or a dry blood spot on an FTA card) during a home or clinic visit. No specific fasting is required, but you should provide a detailed personal and family medical history. Genetic counselling prior to testing is highly recommended to discuss the implications of possible results.
3. How long do results take and what support do I receive afterwards?
Results are typically available within 3 to 4 weeks. You will receive a secure digital report along with a complimentary tele‑guidance session with our Consultant Medical Geneticist, who will explain the clinical significance of your results and guide you on next steps.
UAE Regulatory & Data Privacy Adherence
Your Data, Your Rights
DNA Labs UAE strictly complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and patient consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All genetic data is processed and stored within secure, ISO‑accredited environments.
Clinical & Logistical Metadata
| Test Name | KCNE1 Gene (Jervell and Lange‑Nielsen Syndrome Type 2) Next‑Generation Sequencing DNA Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3 – 4 Weeks |
| Sample Type / Matrix | Whole Blood (EDTA), Extracted DNA, or FTA Card (DBS) |
| Methodology Used | Next‑Generation Sequencing (NGS) – Full Gene Coding Region Analysis |
| ICD-10-CM Code | I45.81 (Long QT Syndrome) |
| LOINC Code | 90215-7 |
| DHA Facility License & Address | License No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians